NCT02569879
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Aspergillosis, +23 more
- Locations
-
- GSK Investigational Site Bogotá, Colombia
Clinical trial condition
Acellular Pertussis
Explore clinical trials studying Acellular Pertussis. Study availability and eligibility vary by location and protocol.
64 public trials
0 recruiting studies
Acellular Pertussis trial results
NCT01568060
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +25 more
- Locations
-
- GSK Investigational Site Seoul, South Korea
NCT01358825
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Morvik, Norway
- GSK Investigational Site Oslo, Norway
- GSK Investigational Site Örebro, Sweden
- GSK Investigational Site Umeå, Sweden
NCT01453998
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Santo Domingo, Dominican Republic
- GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site Mesa, Arizona, United States
- GSK Investigational Site Mesa, Arizona, United States
NCT00148941
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Antioch, California, United States
- GSK Investigational Site Daly City, California, United States
- GSK Investigational Site Fairfield, California, United States
NCT01171989
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
NCT01577732
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Haiphong, Vietnam
NCT02853929
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
- Locations
-
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia